RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer

Documenti analoghi

• Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer
  di: Xingyu Jiang, et al.
  Pubblicazione: (2024)
• Back Cover: Special RCA based sensitive point‐of‐care detection of HPV mRNA for cervical cancer screening
  di: Yi Long, et al.
  Pubblicazione: (2024)
• Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer
  di: Fan‐Wei Yang, et al.
  Pubblicazione: (2024)
• Ezetimibe inhibits the migration and invasion of triple‐negative breast cancer cells by targeting TGFβ2 and EMT
  di: Lingkai Kong, et al.
  Pubblicazione: (2024)
• Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
  di: Xunxi Lu, et al.
  Pubblicazione: (2025)